<DOC>
	<DOCNO>NCT01189032</DOCNO>
	<brief_summary>Dose response relate efficacy safety DE-089 ophthalmic solution examine patient dry eye , use multicenter , randomize , double-blind , parallel group comparison study , optimal concentration determine .</brief_summary>
	<brief_title>Late Phase II Confirmatory Study DE-089 Ophthalmic Solution Patients With Dry Eye</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Those show : Keratoconjunctival disorder confirm vital dye stain Abnormal Schirmer score result Eye disease need therapy dry eye Those need wear contact lenses clinical study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>